Form 4: Repare Therapeutics Director Acquires Stock Options
SEC Filing
Director Thomas Civik acquired stock options in Repare Therapeutics Inc. on June 17, 2024.
Summary
- Thomas Civik, a director of Repare Therapeutics Inc., filed a Form 4 on June 20, 2024.
- The filing reports a transaction that occurred on June 17, 2024, where Civik acquired stock options.
- Civik acquired options to purchase 27,200 common shares at an exercise price of $3.80.
- The options vest in equal monthly installments over twelve months from the grant date, contingent upon continued service.
- Following the transaction, Civik directly owns 27,200 derivative securities (stock options).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a standard transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders, aligning management's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of earliest transaction: acquisition of stock options. |
| 06/16/2034 | Expiration date of the stock options. |
| 06/20/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.